サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1411693

糖尿病診断薬市場：糖尿病タイプ、製品タイプ、糖尿病診断薬タイプ、エンドユーザー別-世界予測2024-2030年

Diabetes Diagnostics Market by Diabetes Type (Diabetes I, Diabetes II, Gestational Diabetes), Product (Biochips, Glucose Monitors, Kits), Diabetes Diagnostics Type, End-User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 180 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
糖尿病診断薬市場：糖尿病タイプ、製品タイプ、糖尿病診断薬タイプ、エンドユーザー別-世界予測2024-2030年
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

糖尿病診断薬市場規模は2023年に203億7,000万米ドルと推定され、2024年には219億1,000万米ドルに達し、CAGR 7.80%で2030年には344億8,000万米ドルに達すると予測されています。

糖尿病診断薬の世界市場

主な市場の統計
基準年[2023］ 203億7,000万米ドル
予測年[2024］ 219億1,000万米ドル
予測年【2030年 344億8,000万米ドル
CAGR（%） 7.8%
糖尿病診断薬 Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは糖尿病診断薬市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、糖尿病診断薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-糖尿病診断薬市場の市場規模および予測は？

2-糖尿病診断薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-糖尿病診断薬市場における技術動向と規制の枠組みは？

4-糖尿病診断薬市場における主要ベンダーの市場シェアは？

5-糖尿病診断薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 高齢者人口の増加に伴い糖尿病有病率が上昇
      • 自宅で血糖値を自己測定する人の増加傾向
      • 糖尿病に対処するための政府の取り組みと公衆衛生キャンペーン
    • 抑制要因
      • 糖尿病診断装置の価格が高い
    • 機会
      • ポイントオブケア検査装置の採用の増加
      • 糖尿病診断薬とデジタルヘルスプラットフォームとの接続における継続的な技術の進歩
    • 課題
      • 糖尿病診断装置の装置精度と校正の問題
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 糖尿病診断薬市場糖尿病の種類別

  • 糖尿病 I
  • 糖尿病Ⅱ
  • 妊娠糖尿病

第7章 糖尿病診断薬市場：製品別

  • バイオチップ
  • グルコースモニター
  • キット
  • ランセット

第8章 糖尿病診断薬市場 糖尿病診断薬タイプ別

  • 血糖検査
  • 空腹時血漿血糖検査
  • 糖化ヘモグロビン（A1C）検査
  • 経口ブドウ糖負荷試験（OGTT）

第9章 糖尿病診断薬市場：エンドユーザー別

  • 診断センター
  • ホームケア設定
  • 病院

第10章 南北アメリカの糖尿病診断薬市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の糖尿病診断薬市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの糖尿病診断薬市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 3M Company
    • Abbott Laboratories
    • Acon Laboratories, Inc.
    • AgaMatrix, Inc.
    • Apex Biotechnology Corporation
    • ARKRAY, Inc.
    • B. Braun Melsungen AG
    • Beckman Coulter, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Diabetomics, Inc.
    • Diazyme Laboratories Inc
    • F. Hoffmann-La Roche Ltd.
    • ICON PLC
    • Medtronic PLC
    • Menarini Group
    • Nova Biomedical Corporation
    • Prestige Diagnostics
    • Sanwa Kagaku Kenkyusho Co, Ltd.
    • Siemens Healthineers AG
    • Sinocare, Inc.
    • Terumo Corporation
    • Tosoh Bioscience, Inc.
    • Trinity Biotech PLC
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. DIABETES DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETES DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DIABETES DIAGNOSTICS MARKET DYNAMICS
  • FIGURE 7. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2023 VS 2030 (%)
  • FIGURE 8. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 10. DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2023 VS 2030 (%)
  • FIGURE 12. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. DIABETES DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. DIABETES DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DIABETES DIAGNOSTICS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 10. DIABETES DIAGNOSTICS MARKET SIZE, BY BIOCHIPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DIABETES DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DIABETES DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DIABETES DIAGNOSTICS MARKET SIZE, BY FASTING PLASMA GLUCOSE TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DIABETES DIAGNOSTICS MARKET SIZE, BY GLYCATED HEMOGLOBIN (A1C) TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DIABETES DIAGNOSTICS MARKET SIZE, BY ORAL GLUCOSE TOLERANCE TEST (OGTT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. DIABETES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DIABETES DIAGNOSTICS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY DIABETES DIAGNOSTICS TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM DIABETES DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 192. DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. DIABETES DIAGNOSTICS MARKET LICENSE & PRICING
目次
Product Code: MRR-2A0283E256C0

[180 Pages Report] The Diabetes Diagnostics Market size was estimated at USD 20.37 billion in 2023 and expected to reach USD 21.91 billion in 2024, at a CAGR 7.80% to reach USD 34.48 billion by 2030.

Global Diabetes Diagnostics Market

KEY MARKET STATISTICS
Base Year [2023] USD 20.37 billion
Estimated Year [2024] USD 21.91 billion
Forecast Year [2030] USD 34.48 billion
CAGR (%) 7.8%
Diabetes Diagnostics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Diabetes Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Diabetes Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Acon Laboratories, Inc., AgaMatrix, Inc., Apex Biotechnology Corporation, ARKRAY, Inc., B. Braun Melsungen AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Diabetomics, Inc., Diazyme Laboratories Inc, F. Hoffmann-La Roche Ltd., ICON PLC, Medtronic PLC, Menarini Group, Nova Biomedical Corporation, Prestige Diagnostics, Sanwa Kagaku Kenkyusho Co, Ltd., Siemens Healthineers AG, Sinocare, Inc., Terumo Corporation, Tosoh Bioscience, Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Diabetes Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Diabetes Type
    • Diabetes I
    • Diabetes II
    • Gestational Diabetes
  • Product
    • Biochips
    • Glucose Monitors
    • Kits
    • Lancets
  • Diabetes Diagnostics Type
    • Blood Glucose Test
    • Fasting Plasma Glucose Test
    • Glycated hemoglobin (A1C) Test
    • Oral Glucose Tolerance Test (OGTT)
  • End-User
    • Diagnostic Centers
    • Homecare Settings
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Diabetes Diagnostics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Diabetes Diagnostics Market?

3. What are the technology trends and regulatory frameworks in the Diabetes Diagnostics Market?

4. What is the market share of the leading vendors in the Diabetes Diagnostics Market?

5. Which modes and strategic moves are suitable for entering the Diabetes Diagnostics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Diabetes Diagnostics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetes with increasing geriatric population
      • 5.1.1.2. Increasing trend of self-monitoring blood glucose levels at home
      • 5.1.1.3. Government initiatives and public health campaigns to address diabetes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of diabetes diagnostic devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing adoption of point-of-care testing devices
      • 5.1.3.2. Ongoing technological advancements in diabetes diagnostics and connectivity with digital health platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Device accuracy and calibration issues with diabetes diagnostic device
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Diabetes Diagnostics Market, by Diabetes Type

  • 6.1. Introduction
  • 6.2. Diabetes I
  • 6.3. Diabetes II
  • 6.4. Gestational Diabetes

7. Diabetes Diagnostics Market, by Product

  • 7.1. Introduction
  • 7.2. Biochips
  • 7.3. Glucose Monitors
  • 7.4. Kits
  • 7.5. Lancets

8. Diabetes Diagnostics Market, by Diabetes Diagnostics Type

  • 8.1. Introduction
  • 8.2. Blood Glucose Test
  • 8.3. Fasting Plasma Glucose Test
  • 8.4. Glycated hemoglobin (A1C) Test
  • 8.5. Oral Glucose Tolerance Test (OGTT)

9. Diabetes Diagnostics Market, by End-User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals

10. Americas Diabetes Diagnostics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Diabetes Diagnostics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Diabetes Diagnostics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. 3M Company
    • 14.1.2. Abbott Laboratories
    • 14.1.3. Acon Laboratories, Inc.
    • 14.1.4. AgaMatrix, Inc.
    • 14.1.5. Apex Biotechnology Corporation
    • 14.1.6. ARKRAY, Inc.
    • 14.1.7. B. Braun Melsungen AG
    • 14.1.8. Beckman Coulter, Inc.
    • 14.1.9. Becton, Dickinson and Company
    • 14.1.10. Bio-Rad Laboratories, Inc.
    • 14.1.11. Danaher Corporation
    • 14.1.12. Diabetomics, Inc.
    • 14.1.13. Diazyme Laboratories Inc
    • 14.1.14. F. Hoffmann-La Roche Ltd.
    • 14.1.15. ICON PLC
    • 14.1.16. Medtronic PLC
    • 14.1.17. Menarini Group
    • 14.1.18. Nova Biomedical Corporation
    • 14.1.19. Prestige Diagnostics
    • 14.1.20. Sanwa Kagaku Kenkyusho Co, Ltd.
    • 14.1.21. Siemens Healthineers AG
    • 14.1.22. Sinocare, Inc.
    • 14.1.23. Terumo Corporation
    • 14.1.24. Tosoh Bioscience, Inc.
    • 14.1.25. Trinity Biotech PLC
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing